Boston, MA, 02/20/2014 – Delta Air Lines, Inc. (NYSE:DAL) along with other U.S. carriers have been alerted for possible bomb threats, According to the official of Federal Department of Homeland Security, the U.S. airlines have been warned against the threats that shoe-bombs could be employed as an attack on commercial passenger flights. The department asked the carriers to screen the passengers’ shoes as well for traces of explosives. The warning followed the government’s earlier placed ban on liquids, aerosols and gels in carry-on baggages ahead of the Olympics.
Prana Biotechnology Ltd. (ADR) (NASDAQ:PRAN) tumbled down badly yesterday by over 13%. The health care provider published its phase II study results for its major drug PBT2 in its treatment for Huntington’s disease. Even as the drug succeeded to fulfill the safety guidelines, there have been some concerns lingering over the efficacy of the drug. While the company is considering the trail as a success, there are critics who stand to believe, contrary based on the overall data. Experts believe that as of now, looking at the future prospects of Prana Biotechnology Ltd. (ADR) (NASDAQ:PRAN)‘s PBT2 for both Huntington’s and Alzheimer’s disease, there is an element of risk present in the company.
William Companies, Inc. (NYSE:WMB) reported its upbeat fourth quarter results after the close of the Wednesday’s trading session. The company attained revenue of $1.66 billion in the quarter, exceeding the analyst consensus by $40 million and posted adjusted earnings per share at $0.22 per share v/s market forecast of $0.21 per share. Net Income for 2013 came at 62 cents per share or $430 million, impacted on account of lower Natural Gas Liquids margins, $99 million of tax expense and an extended outage at Geismar’s Olefins Plant for the complete fourth quarter.These declines were counterbalanced by growth in fee-based revenues at Williams Partners and further by a rise in equity earnings from Access Midstream Partners.